Results 281 to 290 of about 2,534,599 (334)

Clotting and other plasma factors in septicemia [PDF]

, 1980
Fritz, Hans, Jochum, Marianne, Peeters, Hubert, Schießler, Hans, Witte, J.   +4 more
core  

Limitations of rituximab in treating primary immune thrombocytopenia and the therapeutic potentials of alternatives. [PDF]

Curr Opin Hematol
Pan L, Zhu J.
europepmc   +1 more source

Two novel conserved linear B-cell epitopes identified in the S2 subunit of the infectious bronchitis virus spike protein. [PDF]

Virus Res
Zhang L, Li Y, Zhang X, Zhao J, Zhang G, Zhao Y.   +5 more
europepmc   +1 more source

Clinical outcomes and safety of CD47-targeted immunotherapies across hematologic malignancies: a systematic review of monoclonal antibodies and fusion proteins in combination strategies. [PDF]

Clin Exp Med
Mirza W, Dadan S, Ahmad E, Junaid A, Satti TM.   +4 more
europepmc   +1 more source

Evaluating Treatment Success in CGRP Antibody Prophylaxis: A Retrospective Cohort Study Comparing Monthly Migraine Days, MIDAS Scores, and HIT-6 Scores. [PDF]

Pain Ther
Göbel CH, Heinze A, Heinze-Kuhn K, Müller U, Cirkel A, Göbel H.   +5 more
europepmc   +1 more source

A comprehensive strategy for pandemic preparedness with neutralizing monoclonal antibodies. [PDF]

MAbs
Marx C, Piotrowiak R, Schirrmann T, Gebinoga M, Bekeredjian-Ding I, Schober A.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Monoclonal Antibodies: A Review

Current Clinical Pharmacology, 2018
Over the last three decades, monoclonal antibodies (MAbs) have made a striking transformation from scientific tools to powerful human therapeutics. Muromonab CD3 a murine MAb was the first FDA approved therapeutic MAb for the prevention of kidney transplant rejection.
Surjit, Singh, Nitish K, Kumar, Pradeep, Dwiwedi, Jaykaran, Charan, Rimplejeet, Kaur, Preeti, Sidhu, Vinay K, Chugh   +6 more
openaire   +3 more sources

Monoclonal Antibodies

New England Journal of Medicine, 1981
Serologic reagents have played an important role in the diagnosis, treatment, and epidemiology of infectious diseases. A new technology has been developed for generating homogeneous antibodies that can be produced in large amounts and are available indefinitely. This technique promises to increase the reliability and sensitivity of immunoassays and may
M D, Scharff, S, Roberts, P, Thammana
openaire   +4 more sources